This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Drug-distribution regulation does not need to be changed, Swedish watchdog says

( May 14, 2019, 21:14 GMT | Official Statement) -- MLex Summary: Sweden's antitrust authority has said that rules on distributing drugs don't need to be amended, in a report on how to create clearer rules for medicines. Negotiations between Swedish regions and pharmaceutical companies can lead to different financial contract terms on drug distribution, but this does not breach competition law, the watchdog said.Statement follows in Swedish. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections